levodopa has been researched along with diprenorphine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey, D; Bateman, D; Cunningham, VJ; Freemantle, CA; Jones, AK; Jones, T; Kensett, MJ; Luthra, SK; Page, BC; Pike, VW | 1 |
Brooks, DJ; Piccini, P; Weeks, RA | 1 |
Andersson, KE; Andersson, M; Cenci, MA; Johansson, PA | 1 |
3 other study(ies) available for levodopa and diprenorphine
Article | Year |
---|---|
A method of studying pharmacokinetics in man at picomolar drug concentrations.
Topics: Blood-Brain Barrier; Carbon Radioisotopes; Diprenorphine; Electrons; Fluorine Radioisotopes; Humans; Isotope Labeling; Levodopa; Pharmacokinetics; Tissue Distribution; Whole-Body Counting | 1991 |
Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias.
Topics: Adult; Aged; Antiparkinson Agents; Binding, Competitive; Brain Chemistry; Brain Mapping; Carbon Radioisotopes; Caudate Nucleus; Diprenorphine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Narcotic Antagonists; Occipital Lobe; Parkinson Disease; Putamen; Receptors, Opioid; Thalamic Nuclei | 1997 |
Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
Topics: Animals; Basal Ganglia; Behavior, Animal; Binding Sites; Cerebral Cortex; Diprenorphine; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Enkephalins; Female; Levodopa; Narcotic Antagonists; Oxidopamine; Protein Precursors; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; RNA, Messenger; Sympatholytics; Tritium | 2001 |